IL6 and hematoma: For example, both IL-6 and CRP are associated with neuroinflammation [21,22]; prior observations have suggested that IL-6 serum concentrations are an independent predictor of early hematoma growth and associated with poor 3-month outcomes, whereas CRP is independently associated with increased 30-day mortality post-ICH [23,24].